T. Pekol

Systematic development of an UPLC-MS/MS method for the determination of tricyclic antidepressants in human urine.

Erin E. Chambers, D. Diehl, M. Woodcock, 2014, Journal of pharmaceutical and biomedical analysis.

HUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITES

F. Hsieh, E. Baronas, L. Gan, 2005, Drug Metabolism and Disposition.

Preconcentration of Organic Compounds from Water across Dialysis Membranes into Micellar Media.

J. Cox, T. Pekol, 1995, Environmental science & technology.

Interaction with micelles as a driving force for uphill transport of organic cations across ion exchange membranes.

J. Cox, T. Pekol, N. Poopisut, 1994, Talanta.

Identification of Novel Opioid Interferences using High-Resolution Mass Spectrometry.

Charlene Johnson, T. Pekol, A. C. Muñoz-Muñoz, 2018, Journal of analytical toxicology.

Characterization of an Amphetamine Interference from Gabapentin in an LC-HRMS Method.

Charlene Johnson, R. Hyland, T. Pekol, 2019, Journal of analytical toxicology.

Norbuprenorphine Interferences in Urine Drug Testing LC–MS-MS Confirmation Methods from Quetiapine Metabolites

Lynn R. Sullivan, T. Pekol, A. C. Muñoz-Muñoz, 2021, Journal of analytical toxicology.

Elucidation of potential bortezomib response markers in mutliple myeloma patients.

F. Hsieh, G. Miwa, R. Guerciolini, 2009, Journal of pharmaceutical and biomedical analysis.